Carnitine Profile and Effect of Suppletion in Children with Renal Fanconi Syndrome due to Cystinosis

Abstract

Background: Cystinosis is an autosomal recessive disorder marked by intralysosomal cystine accumulation. Patients present with generalized proximal tubular dysfunction called renal Fanconi syndrome. Urinary carnitine loss results in plasma and muscle carnitine deficiency, but no clinical signs of carnitine deficiency have been described. Also, the optimal dose of carnitine supplementation is undefined. This study aimed to determine whether currently recommended carnitine doses result in adequate correction of plasma carnitine.Methods: Five cystinosis patients with renal Fanconi syndrome, aged 2-18 years, were included. L-carnitine was prescribed 50 mg/kg/day since diagnosis: median 36 (range 18-207) months. Total and free plasma and urine carnitine and carnitine profiles were measured at study onset, after stopping L-carnitine for 3 months and 3 months after reintroducing L-carnitine 50 mg/kg/day.Results: At study onset, plasma free carnitine was normal in all patients, total carnitine (1/5), acetylcarnitine (3/5), and several short-and medium-chain acylcarnitines 10 carbons (5/5) were increased indicating carnitine over-supplementation. Three months after cessation, carnitine profiles normalized and 3/5 patients showed plasma carnitine deficiency. Three months after reintroduction, plasma free carnitine normalized in all patients, however, carnitine profiles were disturbed in 4/5 patients. Urine free carnitine, acetylcarnitine, and acylcarnitines 10 carbons were increased in all patients independent of carnitine supplementation.Conclusion: Administration of recommended doses L-carnitine (50 mg/kg/day) resulted in over-supplementation. Although the drug is considered to be rather safe, long-term effects of over-supplementation remain unknown warranting cautious use of high doses. Plasma carnitine profile might be used as a monitor, to prevent overdosing.

Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease

“…Two Clostridium IV species including Clostridium leptum and Eubacterium siraeum were significantly decreased in our CKD rats. C. leptum can induce stimulation of Treg cells and inhibit the inflammatory response [68]. The observed depletion of the antiinflammatory bacteria may contribute to the inflammatory state in CKD rats.…”

A Case of Atypical Systemic Primary Carnitine Deficiency in Saudi Arabia

“…It helps differentiating primary carnitine deficiency from many other causes of carnitine deficiency, such as some organic acidemias, defects of fatty acid oxidation, defects of the carnitine cycle, 8 and generalized renal tubular dysfunction including renal Fanconi syndrome. 21 In fact, at least 15 syndromes have been reported to have carnitine deficiency secondary to genetic defects of intermediary metabolism or to other conditions. 2 , 8 …”

Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy

“…in cystinosis) Fanconi syndrome, tubular reabsorption of many compounds including carnitine was dramatically impaired, whereas normally carnitine is almost entirely (97%) reabsorbed in the tubules of the kidneys. It is known that low carnitine levels in blood is typical for these disorders, plasma and muscle carnitine deficiency (17)(18)(19)(20).…”